Primary Immunodeficiency Diseases Market to Reach US$ 7.5 Bn by the End of 2023
The global primary immunodeficiency disease (PIDD) market is characterized by the strong position of two major player namely, Grifols S.A. and CSL Behring LLC. These two market vendors have performed unusually well in the global market and have emerged as the undisputed leaders of the industry. The other players that operate in the global market for primary immunodeficiency diseases are at a risk of being outrun or eliminated from the market by the dominance of these two leading vendors. Grifols...
View full press release